Christine Palmay and Dr
European Elder (Sambucus nigra)
A healthy gut microbiome is essential to stimulate GLP-1 release
For the sperm quality analysis, the data were divided into five age groups: the 2024 years old group (n = 102, with an average age of 23.66 0.554 years), the 2529 years old group (n = 1,789, 27.70 1.212 years), the 3034 years old group (n = 3,026, 32.83 1.392 years), the 3539 years old group (n = 1,345, 36.53 1.369 years), and the over-40 years old group (n = 543, 42.22 2.738 years)
I = 49%, p = 0.033) (Fig

In a third study, Julio Rosenstock, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues found that the mean HbA1c reductions were significantly greater with cagrilintide-semaglutide (2.4 mg each and 1.0 mg each: 2.33 and 2.10 percent, respectively) versus placebo (0.66 percent) at week 40 in 274 adults with type 2 diabetes using basal insulin."These findings support a potential new therapeutic tool to effectively improve HbA1c levels well below 7 percent in such a challenging population," Rosenstock said in a statement.Several authors from all three studies disclosed ties to biopharmaceutical companies, including Novo Nordisk, which is developing cagrilintide and funded the studies.Abstract/Full Text - Aroda (subscription or payment may be required)Abstract/Full Text - Buso (subscription or payment may be required)Abstract/Full Text - Rosenstock (subscription or payment may be required)More Information.Sign up for our weekly HealthDay newsletter